Common Audit Observations and FDA 483 Findings for Water Systems
Learn what FDA investigators actually flag most often when auditing pharmaceutical water systems — sampling gaps, sanitization failures, monitoring lapses, validation shortfalls, CAPA deficiencies, and broader GMP compliance issues.